Company Aequus Pharmaceuticals Inc Toronto S.E.
Equities
CA0076361033
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Drugs
82.4
%
| 3 | 96.2 % | 1 | 82.4 % | -56.45% |
Promotional Services
17.6
%
| 0 | 3.8 % | 0 | 17.6 % | +133.68% |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 3 | 100.0 % | 1 | 100.0 % | -49.17% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Anne Stevens
FOU | Founder | - | 12-12-31 |
Douglas Janzen
CEO | Chief Executive Officer | 56 | 13-01-02 |
Ann Fehr
DFI | Director of Finance/CFO | 55 | 16-07-21 |
Andre Mbeng
AUD | Comptroller/Controller/Auditor | 45 | 20-10-31 |
Grant Larsen
PRN | Corporate Officer/Principal | - | 20-08-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Janzen
CEO | Chief Executive Officer | 56 | 13-01-02 |
Marc Lustig
BRD | Director/Board Member | 51 | 21-02-14 |
Director/Board Member | 54 | 14-12-17 | |
Anne Stevens
FOU | Founder | - | 12-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 132,634,431 | 113,163,965 ( 85.32 %) | 0 | 85.32 % |
Company contact information
Aequus Pharmaceuticals, Inc.
200 Granville Street Suite 2820
V6C 1S4, Vancouver
+604 336 7906
http://www.aequuspharma.caSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+32.86% | 704B | |
+27.79% | 577B | |
-4.57% | 348B | |
+18.36% | 327B | |
+4.60% | 288B | |
+14.68% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-4.64% | 147B |